Market Size of Global Electromyography Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 10.10 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Electromyography Devices Market Analysis
The electromyography devices market is expected to record a CAGR of 10.1% over the forecast period.
COVID-19 had a notable impact on the overall healthcare industry. As per the article published in 2021 under the title 'Musculoskeletal involvement of COVID-19: a review of imaging', myalgia was a common clinical feature of COVID-19. Moreover, there were reports of a variety of neuromuscular and rheumatologic side effects, such as myositis, neuropathy, arthropathy, and soft tissue abnormalities, that are linked to COVID-19 infection and disease progression. As musculoskeletal abnormalities boosted during the pandemic, diagnostic tests were adopted in a high proportion. Hence, COVID-19 had a significant impact on the electromyography devices market.
The increasing prevalence of neuromuscular disorders, such as motor neuron diseases, myasthenia gravis, myopathy, Parkinson's disease, peripheral neuropathy, and amyotrophic lateral sclerosis, and the surge in minimally invasive surgeries are expected to drive the market growth. For instance, as per the article published in 2020 under the title 'The prevalence of hereditary neuromuscular disorders in Northern Norway', the survey conducted showed that total prevalence was higher in hereditary neuromuscular disorders than previously hypothesized in European population-based studies. 542 people in Northern Norway had a genetic neuromuscular condition as of January 2020. The prevalence was especially high for myotonia congenita and limb-girdle muscular dystrophy. In addition, according to the Parkinson's Disease Foundation 2022 update, approximately 60,000 Americans are diagnosed with Parkinson's Disease (PD) each year. The increasing prevalence of this disease is anticipated to propel market growth over the forecast period.
Technological advancements in electromyography (EMG) systems and the growing demand for portable EMG devices to curb the rising hospital and healthcare-associated costs are the key drivers that are likely to fuel market growth. For instance, advancements in technologies, such as the RS-EMGx EMG System, which enables 4 channels of EMG recordings simultaneously from a single subject, are likely to boost the market growth.
As per the aforementioned factors, the electromyography devices market is anticipated to grow over the forecast period. However, biocompatibility issues with medical electrodes restrain the market growth.
